Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 18.07.2023       Spexis AG
First Berlin Equity Research GmbH CH0106213793

First Berlin Equity Research has published a research update on Spexis AG (ISIN: CH0106213793). Analyst Christian Orquera reiterated his BUY rating and maintained his CHF 1.80 price target. Abstract: Spexis AG reported FY/22 results which, adjusted for non-cash goodwill impairment of CHF 3.4m, were roughly as expected. Adjusted EBIT amounted to [ … ]
Technical analysis
To the publication
Tue, 18.07.2023       Spexis AG
First Berlin Equity Research GmbH CH0106213793

First Berlin Equity Research has published a research update on Spexis AG (ISIN: CH0106213793). Analyst Christian Orquera reiterated his BUY rating and maintained his CHF 1.80 price target. Abstract: Spexis AG reported FY/22 results which, adjusted for non-cash goodwill impairment of CHF 3.4m, were roughly as expected. Adjusted EBIT amounted to [ … ]
Technical analysis
To the publication
Tue, 18.07.2023       Pharming
First Berlin Equity Research GmbH NL0010391025

First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010391025). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 1.80 to EUR 1.50. Abstract: Pharming's orphan drug, Joenja, for the treatment of the rare disease, activated PI3K delta syndrome (APDS), was approved in t [ … ]
Technical analysis
To the publication
Tue, 18.07.2023       Pharming
First Berlin Equity Research GmbH NL0010391025

First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010391025). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 1.80 to EUR 1.50. Abstract: Pharming's orphan drug, Joenja, for the treatment of the rare disease, activated PI3K delta syndrome (APDS), was approved in t [ … ]
Technical analysis
To the publication
Wed, 12.07.2023       Diversified Energy PLC
First Berlin Equity Research GmbH GB00BYX7JT74

First Berlin Equity Research has published a research update on Diversified Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY rating and maintained his GBp 180.00 price target. DEC looks set to be a prime beneficiary of a multi-year LNG-driven gas price rally, which is currently in its early stages, but will likely be su [ … ]
Technical analysis
To the publication
Wed, 12.07.2023       Diversified Energy PLC
First Berlin Equity Research GmbH GB00BYX7JT74

First Berlin Equity Research has published a research update on Diversified Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY rating and maintained his GBp 180.00 price target. DEC looks set to be a prime beneficiary of a multi-year LNG-driven gas price rally, which is currently in its early stages, but will likely be su [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       MPH Health Care AG
First Berlin Equity Research GmbH DE000A289V03

First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 54,00 auf EUR 59,00. Zusammenfassung: Der Net Asset Value (NAV) von MPH belief sich in Q1 auf €188 Mio. gegenüber €221 M [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       MPH Health Care AG
First Berlin Equity Research GmbH DE000A289V03

First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 54,00 auf EUR 59,00. Zusammenfassung: Der Net Asset Value (NAV) von MPH belief sich in Q1 auf €188 Mio. gegenüber €221 M [ … ]
Technical analysis
To the publication
Thu, 06.07.2023       CR Capital AG
First Berlin Equity Research GmbH DE000A2GS625

First Berlin Equity Research hat ein Research Update zu CR Capital AG (ISIN: DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 53,00 auf EUR 50,00. Zusammenfassung: Mit dem Jahresbericht konnte CR Capital seinen Ruf als grüner Unternehmensbauer weiter festigen. Der Ne [ … ]
Technical analysis
To the publication
Thu, 06.07.2023       CR Capital AG
First Berlin Equity Research GmbH DE000A2GS625

First Berlin Equity Research hat ein Research Update zu CR Capital AG (ISIN: DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 53,00 auf EUR 50,00. Zusammenfassung: Mit dem Jahresbericht konnte CR Capital seinen Ruf als grüner Unternehmensbauer weiter festigen. Der Ne [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 22.11.2024, Calendar Week 47, 327th day of the year, 39 days remaining until EoY.